Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jorinde AW Polderman, Robert van Wilpe, Jan H Eshuis, Benedikt Preckel & Jeroen Hermanides. (2016) Ambulatory anesthesia: optimal perioperative management of the diabetic patient. Ambulatory Anesthesia 3, pages 13-22.
Read now
Read now
Charles Shaefer, Debbie Hinnen & Christopher Sadler. (2016) Hypoglycemia and diabetes: increased need for awareness. Current Medical Research and Opinion 32:9, pages 1479-1486.
Read now
Read now
Carla Francés Artigas, Victoria Stokes, Garry D Tan & Michael J Theodorakis. (2015) Insulin dose adjustments with add-on glucagon-like peptide-1 receptor (GLP-1R) agonists in clinical practice. Expert Opinion on Pharmacotherapy 16:10, pages 1417-1421.
Read now
Read now
Andres Digenio, Sudeep Karve, Sean D. Candrilli & Mehul Dalal. (2014) Prandial Insulin versus Glucagon-Like Peptide-1 Added to Basal Insulin: Comparative Effectiveness in the Community Practice Setting. Postgraduate Medicine 126:6, pages 49-59.
Read now
Read now
Sheila A Doggrell. (2013) Exenatide extended-release; clinical trials, patient preference, and economic considerations. Patient Preference and Adherence 7, pages 35-45.
Read now
Read now
Bo Ahrén. (2013) Incretin therapy for type 2 diabetes: GLP-1 receptor agonists and DPP-4 inhibitors. European Diabetes Nursing 10:1, pages 31-36.
Read now
Read now
Articles from other publishers (4)
Alex Ramírez-Rincón, Carlos E. Builes-Montaño, Jaime A. Hincapié-García, Victor M. Blanco & José F. Botero-Arango. (2022) Short-Term Effectiveness and Reduction in Insulin Requirements in Patients With Type 2 Diabetes Treated With IdegLira in a Real-World Setting. Frontiers in Endocrinology 13.
Crossref
Crossref
Luciano Zenari, Andrea Da Porto, Lorena De Moliner, Francesca Lugli, Valeria Guazzoni, Gloria Groppelli, Laura Molteni, Massimo Bracaccia, Vera Frison, Natalino Simioni, Barbara Bonsembiante, Cesare Miranda & Annunziata Lapolla. (2020) Real-World Evaluation of Glycemic Outcomes and Extra-Glycemic Parameters in Diabetic Patients Treated with the Combined Formulation Degludec–Liraglutide (Ideglira). Diabetes Therapy 12:1, pages 197-209.
Crossref
Crossref
Fujikawa T, Kato Y, Bando H, Kakutani H, Kawata T, Yamamoto M, Wada K, Ishikura K, Shirai Y, Narutaki M, Matsuzaki S & Waka S. (2020) The Administration of Xultophy for Diabetic Patients on Hemodialysis. Diabetes Research: Open Access 2:3, pages 72-78.
Crossref
Crossref
Jennifer Goldman & Jennifer M. Trujillo. (2017) iGlarLixi: A Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide for the Treatment of Type 2 Diabetes. Annals of Pharmacotherapy 51:11, pages 990-999.
Crossref
Crossref